Exane Derivatives’s Stellantis STLA Stock Holding History

Exane Derivatives’s Portfolio STLA Stock Details STLA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-25	Closed	-$137K	–	1085
2021 Q4	$137K	Sell	25 -1,169	-98%	-$22.5K	0.03%	405
2021 Q3	$4.66M	Buy	1,194 +120	+11%	+$2.38K	1.12%	13
2021 Q2	$4.76M	Sell	1,074 -684	-39%	-$12.9K	1.08%	13
2021 Q1	$5.56M	Buy	1,758 +1,132	+181%	+$19K	1.59%	6
2020 Q4	$2.28M	Sell	626 -6,599	-91%	-$97.3K	0.67%	29
2020 Q3	$4.42M	Buy	7,225 +2,277	+46%	+$25.3K	1.28%	18
2020 Q2	$2.53M	Buy	4,948 +1,309	+36%	+$11.3K	0.68%	36
2020 Q1	$199K	Sell	3,639 -186	-5%	-$2.2K	0.06%	199
2019 Q4	$2.57M	Sell	3,825 -1,710	-31%	-$24.7K	0.48%	70
2019 Q3	$2.07M	Sell	5,535 -1,213	-18%	-$16.2K	0.37%	68
2019 Q2	$2.73M	Sell	6,748 -259	-4%	-$3.76K	0.48%	65
2019 Q1	$2.56M	Sell	7,007 -27	-0.4%	-$415	0.51%	63
2018 Q4	$10M	Sell	7,034 -738	-9%	-$11.9K	1.8%	10
2018 Q3	$4.51M	Sell	7,772 -920	-11%	-$16.3K	0.85%	21
2018 Q2	$7.12M	Buy	8,692 +872	+11%	+$19.1K	1.19%	18
2018 Q1	$9.08M	Sell	7,820 -1,345	-15%	-$29.5K	1.82%	8
2017 Q4	$10.4M	Buy	9,165 +2,987	+48%	+$52.5K	1.79%	12
2017 Q3	$13.4M	Buy	6,178 +2,923	+90%	+$40.4K	2.51%	7
2017 Q2	$3.53M	Sell	3,255 -959	-23%	-$10.2K	0.76%	28
2017 Q1	$5.44M	Buy	4,214 +57	+1%	+$613	1.23%	14
2016 Q4	$4.19M	Sell	4,157 -4,524	-52%	-$33.8K	0.83%	23
2016 Q3	$668K	Buy	+8,681	New	+$57K	0.1%	137
2016 Q2	–	Sell	-5,718	Closed	-$912K	–	622
2016 Q1	$912K	Sell	5,718 -3,431	-38%	-$24.8K	0.12%	96
2015 Q4	$3.07M	Sell	9,149 -538	-6%	-$5.05K	0.42%	50
2015 Q3	$3.06M	Sell	9,687 -189	-2%	-$1.81K	0.39%	51
2015 Q2	$4.39M	Buy	9,876 +1,645	+20%	+$16.9K	0.47%	47
2015 Q1	$7.44M	Buy	8,231 +5,395	+190%	+$50.4K	0.82%	38
2014 Q4	$1.47M	Buy	+2,836	New	+$21K	0.2%	81

Other funds holding STLA

Bpifrance Maisons Alfort, Cedex, France $1.65B AUM 19.85% 1-Year Est. Return

Amundi Paris, France $367B AUM 31.23% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

BOI

Bank of Italy Rome, Italy $2.21B AUM 9.01% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Exane Derivatives's STLA Position: Q2 2022 in Review

Exane Derivatives reduced its Stellantis (STLA) stake by 90% in Q2 2022, selling an estimated $3.83M and leaving 31,141 shares worth $381K. The position accounts for 0.22% of the portfolio, ranked #112.

Exane Derivatives first reported a position in STLA in Q1 2015 and has held it in 23 quarters since. The position peaked at $31.4M in Q4 2021. 333 funds tracked by Wall St. Rank hold STLA as of Q2 2022.

Exane Derivatives held 31,141 shares of Stellantis worth $381K as of Q2 2022.
Exane Derivatives sold 270,625 Stellantis shares in Q2 2022, an estimated $3.83M.
Stellantis made up 0.22% of Exane Derivatives's portfolio in Q2 2022, its #112 holding.
Exane Derivatives first reported a position in Stellantis in Q1 2015 and has held it in 23 quarters since.
Exane Derivatives's Stellantis position peaked at $31.4M in Q4 2021.
333 funds tracked by Wall St. Rank held Stellantis as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.